Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators - 842

Details for Australian Patent Application No. 2008260717 (hide)

Owner AstraZeneca AB

Inventors Isaac, Methvin; Ma, Fupeng; Empfield, James; Slassi, Abdelmalik; Egle, Ian; Clayton, Joshua; Folmer, James

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2008260717

PCT Pub. Number WO2008/150233

Priority 60/942,553 07.06.07 US

Filing date 5 June 2008

Wipo publication date 11 December 2008

Acceptance publication date 19 January 2012

International Classifications

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

24 December 2009 PCT application entered the National Phase

  PCT publication WO2008/150233 Priority application(s): WO2008/150233

19 January 2012 Application Accepted

  Published as AU-B-2008260717

17 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008260719-Closure for beverage container and method for closing an opening of a container

2008260714-Silica-based sols